OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 72. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	450
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	319
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	268
Source-sink connectivity: a novel interictal EEG marker for seizure localization	234
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	228
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	223
We’re all in this together: a rejoinder to Masud Husain’s (rant) editorial	213
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	212
Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism	210
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	207
Thalamic stereo EEG: a clinically justified extension of hypothesis-driven intracranial exploration	193
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	189
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	180
In vivo self-assembled siRNAs ameliorate neurological pathology in TDP-43-associated neurodegenerative disease	176
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	165
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	162
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	160
Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages	159
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases	153
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	153
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	151
Maternal microbiome-derived propionate regulates offspring myelination via histone lactylation	144
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing	139
The vascular contribution of apolipoprotein E to Alzheimer’s disease	135
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	134

A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	134
Dopamine and the dynamics of subthalamic and leg muscle activities in parkinsonian stepping	129
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	123
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	121
The RAB3A hot spot variant R83W causes spasticity as part of the ataxia-spasticity spectrum	117
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models	117
Deep brain stimulation: a tale of two targets … and closing the loop	115
The use of optical coherence tomography in neurology: a review	115
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	113
Brain repair mechanisms after cell therapy for stroke	111
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	108
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	106
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	106
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	101
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	100
Speech and language markers of neurodegeneration: a call for global equity	99
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	99
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	98
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability	98
Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40	97
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	96
Demystifying interictal discharges and seizure initiation in focal epilepsy	96
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	93
Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy	91
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	89
Natural experiment on neuroinflammatory disease incidence and infection links pre- and post-COVID-19	87
Routes of precursors’ migration in remyelination	86
The three deceits of bureaucracy	85
How COVID-19 affects microvessels in the brain	84
New mechanistic insights into hereditary spastic paraplegias	83
Extra-cranial cholinergic lesions in dementia with Lewy bodies	83
Preclinical type 2 diabetes mellitus subtypes: new insights into diabetes, depression and dementia	82
Functional network reorganization precedes apathy in Parkinson’s disease: a neural marker of risk?	82
Loss-of-function variants inMYCBP2cause neurobehavioural phenotypes and corpus callosum defects	82
Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy	77
Distinct contribution of spinal neuropeptide Y and NPY1R neurons to morphine analgesia	77
Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders	77
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	76
Biallelic null variants in PNPLA8 cause microcephaly by reducing the number of basal radial glia	76
From phenomena to phrasing: rethinking seizure classification through history	76
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults	76
The low dimensionality of post-stroke cognitive deficits: it’s the lesion anatomy!	76
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration	76
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases	75
Deciphering the impact of coding and non-coding SCN1A gene variants on RNA splicing	73
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapy	73
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis	73
Multimodal mapping of regional brain vulnerability to focal cortical dysplasia	72